Mehul Mehta
Dr. Mehta is currently an Adjunct Professor at the Yale School of Public Health, where his work focuses on innovation and the application of AI in healthcare delivery. He is the co-founder of MCCM, a novel distributed healthcare entity expanding in Canada through a Public-Private Partnership model. He serves as an advisor and board member to select companies, ahospitals, and non-profits, guiding organizations in leveraging AI to improve care quality and system performance. His governance roles include serving on the Advisory Board for a new healthcare district for the Sovereign of Sharjah (UAE), the Board of Trustees of the American Nurses Foundation, and the International Advisory Board of the American Nurses Credentialing Center.
As Senior Medical Advisor to Albright Stonebridge Group, where he previously served as Chief Medical Officer and Chair of Health Solutions, Dr. Mehta led global health guidance during the COVID-19 pandemic and coordinated a rapid, multi-stakeholder response to the Delta variant crisis in India, including the establishment of critical genomic sequencing capacity in Mumbai.
Over three decades, Dr. Mehta has worked in more than 33 countries, helping design and implement hospitals, health systems, and healthcare clusters across Asia, the Middle East, Australia, and beyond. He has been instrumental in establishing internationally accredited hospital systems, healthcare free zones, and large-scale health clusters. A longtime Clinical Instructor at Harvard Medical School, he has also contributed extensively to global vision health, health systems research, and the global discourse on AI in healthcare.
Dr. Mehta holds advanced medical and neuroscience degrees and executive training from leading global institutions.
